Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids

Phillipson, 1985, Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia, N Engl J Med, 312, 1210, 10.1056/NEJM198505093121902 Harris, 1997, n-3 Fatty acids and serum lipoproteins, Am J Clin Nutr, 65, 1645S, 10.1093/ajcn/65.5.1645S Maki, 2005, Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol, J Am Coll Nutr, 24, 189, 10.1080/07315724.2005.10719465 Davidson, 1997, Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia, J Am Coll Nutr, 16, 236, 10.1080/07315724.1997.10718680 Park, 2003, Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance, J Lipid Res, 44, 455, 10.1194/jlr.M200282-JLR200 Kersten, 1999, Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting, J Clin Invest, 103, 1489, 10.1172/JCI6223 Pegorier, 2004, Control of gene expression by fatty acids, J Nutr, 134, 2444S, 10.1093/jn/134.9.2444S Kersten, 2001, Mechanisms of nutritional and hormonal regulation of lipogenesis, EMBO Rep, 2, 282, 10.1093/embo-reports/kve071 Shelness, 2001, Very-low-density lipoprotein assembly and secretion, Curr Opin Lipidol, 12, 151, 10.1097/00041433-200104000-00008 Clarke, 2001, Polyunsaturated fatty acid regulation of gene transcription, J Nutr, 131, 1129, 10.1093/jn/131.4.1129 Price, 2000, Omega-3 polyunsaturated fatty acid regulation of gene expression, Curr Opin Lipidol, 11, 3, 10.1097/00041433-200002000-00002 Jump, 1999, Regulation of gene expression by dietary fat, Annu Rev Nutr, 19, 63, 10.1146/annurev.nutr.19.1.63 Pawar, 2003, The role of liver X receptor-α in the fatty acid regulation of hepatic gene expression, J Biol Chem, 278, 40736, 10.1074/jbc.M307973200 Xu, 1999, Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids, J Biol Chem, 274, 23577, 10.1074/jbc.274.33.23577 Coleman, 2004, Enzymes of triacylglycerol synthesis and their regulation, Prog Lipid Res, 43, 134, 10.1016/S0163-7827(03)00051-1 Hertz, 2001, Suppression of hepatocyte nuclear factor-4α by acyl-CoA thioesters of hypolipidemic peroxisome proliferators, Biochem Pharmacol, 61, 1057, 10.1016/S0006-2952(01)00578-0 Claudel, 2005, The Farnesoid X receptor, Arterioscler Thromb Vasc Biol, 25, 2020, 10.1161/01.ATV.0000178994.21828.a7 Sirvent, 2004, The farnesoid X receptor induces very low density lipoprotein receptor gene expression, FEBS Lett, 566, 173, 10.1016/j.febslet.2004.04.026 Claudel, 2003, Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression, Gastroenterology, 125, 544, 10.1016/S0016-5085(03)00896-5 Zhao, 2004, Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets, DNA Cell Biol, 23, 519, 10.1089/1044549041562267 Jump, 2002, The biochemistry of n-3 polyunsaturated fatty acids, J Biol Chem, 277, 8755, 10.1074/jbc.R100062200 Pawar, 2003, Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes, J Biol Chem, 278, 35931, 10.1074/jbc.M306238200 Clarke, 1998, Polyunsaturated fatty acid inhibition of fatty acid synthase transcription is independent of PPAR activation, Z Ernahrungswiss, 37, 14 Krey, 1997, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Mol Endocrinol, 11, 779, 10.1210/mend.11.6.0007 Li, 2005, EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells, Kidney Int, 67, 867, 10.1111/j.1523-1755.2005.00151.x Worgall, 1998, Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element binding protein, J Biol Chem, 273, 25537, 10.1074/jbc.273.40.25537 Mater, 1999, Sterol response element binding protein 1c (SREBP-1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription, J Biol Chem, 274, 32725, 10.1074/jbc.274.46.32725 Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J Clin Invest, 113, 1408, 10.1172/JCI21025 Yoshikawa, 2003, Mol Endocrinol, 17, 1240, 10.1210/me.2002-0190 Pan, 2004, Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production, J Clin Invest, 113, 1277, 10.1172/JCI19197 Krauss, 2004, Hold the antioxidants and improve plasma lipids?, J Clin Invest, 113, 1253, 10.1172/JCI200421637 2002, MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals, Lancet, 360, 23, 10.1016/S0140-6736(02)09328-5 Calabresi, 2000, Omacor in familial combined hyperlipidemia, Atherosclerosis, 148, 387, 10.1016/S0021-9150(99)00267-1 Eritsland, 1995, Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease, Am J Clin Nutr, 61, 831, 10.1093/ajcn/61.4.831